share_log
Reuters ·  May 8 16:21
Arcus Biosciences Inc -Well-Positioned to Advance Full Pipeline With $1.1 Bln in Cash, Cash Equivalents and Marketable Securities and Runway Into 2027
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment